BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25551306)

  • 1. Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis.
    Tai AS; Kidd TJ; Whiley DM; Ramsay KA; Buckley C; Bell SC;
    Pathology; 2015 Feb; 47(2):156-60. PubMed ID: 25551306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the resistance mechanism and homology of carbapenems-resistant Pseudomonas aeruginosa].
    Liu Y; Deng Q; Yu Y; Cao X; Xu Q; Wan L
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):15-20. PubMed ID: 24684984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods.
    Akhi MT; Khalili Y; Ghotaslou R; Kafil HS; Yousefi S; Nagili B; Goli HR
    J Chemother; 2017 Jun; 29(3):144-149. PubMed ID: 27443547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
    Zhang JF; Chen BL; Xin XY; Zhao HB; Wang HY; Song H; Xu ZK
    Microb Drug Resist; 2009 Mar; 15(1):41-5. PubMed ID: 19226194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
    Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients.
    Ferreira AG; Leão RS; Carvalho-Assef AP; da Silva ÉA; Firmida Mde C; Folescu TW; Paixão VA; Santana MA; de Abreu e Silva FA; Barth AL; Marques EA
    APMIS; 2015 Dec; 123(12):1061-8. PubMed ID: 26522829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.
    Tai AS; Bell SC; Kidd TJ; Trembizki E; Buckley C; Ramsay KA; David M; Wainwright CE; Grimwood K; Whiley DM
    PLoS One; 2015; 10(12):e0144022. PubMed ID: 26633539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
    Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
    Hong JS; Yoon EJ; Lee H; Jeong SH; Lee K
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7216-7223. PubMed ID: 27671068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
    Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant Pseudomonas aeruginosa clinical isolates: a multicenter study in Mexican hospitals.
    Garza-Ramos U; Barrios H; Reyna-Flores F; Tamayo-Legorreta E; Catalan-Najera JC; Morfin-Otero R; Rodríguez-Noriega E; Volkow P; Cornejo-Juarez P; González A; Gaytan-Martinez J; Del Rocío Gónzalez-Martínez M; Vazquez-Farias M; Silva-Sanchez J
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):135-7. PubMed ID: 25467172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
    Pellegrino FL; Casali N; Nouér SA; Riley LW; Moreira BM
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):214-6. PubMed ID: 18308497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
    Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
    J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.